# HTG MOLECULAR DIAGNOSTICS IN (HTGMQ)

> Institutional ownership reported to the SEC as of Q1 2023, from Form 13F filings. Source: https://holderbook.com/stocks/HTGMQ/

- Reporting holders: 10
- Reported value: $67.3K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [VANGUARD GROUP INC](https://holderbook.com/funds/102909-vanguard-group-inc/) | $39.7K | 14,692 | 0.0% | 1 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $14.0K | 5,198 | 0.0% | 2 |
| [Tower Research Capital LLC (TRC)](https://holderbook.com/funds/1533421-tower-research-capital-llc-trc/) | $4.0K | 1,481 | 0.0% | 2 |
| [BlackRock Inc.](https://holderbook.com/funds/1364742-blackrock-inc/) | $3.5K | 1,289 | 0.0% | 2 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $2.4K | 884 | 0.0% | 2 |
| [HighMark Wealth Management LLC](https://holderbook.com/funds/1802451-highmark-wealth-management-llc/) | $1.6K | 580 | 0.0% | 2 |
| [Nordwand Advisors, LLC](https://holderbook.com/funds/1962713-nordwand-advisors-llc/) | $1.4K | 500 | 0.0% | 1 |
| [Allworth Financial LP](https://holderbook.com/funds/1555170-allworth-financial-lp/) | $754 | 279 | 0.0% | 2 |
| [WELLS FARGO & COMPANY/MN](https://holderbook.com/funds/72971-wells-fargo-company-mn/) | $35 | 13 | 0.0% | 2 |
| [TCI Wealth Advisors, Inc.](https://holderbook.com/funds/1583751-tci-wealth-advisors-inc/) | $6 | 2 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2023 | 10 | $67.3K |
| Q4 2022 | 8 | $66.2K |
| Q4 2020 | 1 | $18.0K |
| Q3 2020 | 1 | $2.0K |
| Q4 2018 | 1 | $32.0K |